β-Apo-13-carotenone (D'Orenone) acts as a natural RXRα antagonist; it antagonizes 9-cis-retinoic acid (9cRA)-mediated activation of RXRα with high potency (effective at concentrations as low as 1 nM) and competes with 9cRA for binding to RXRα with similar affinity (7–8 nM); it induces the formation of transcriptionally silent RXRα tetramers; it modulates adipocyte differentiation by inducing 3T3-L1 adipocyte marker gene expression.